DIANA CDK Panel: Panel of 24 cyclin dependent kinases

(DIANA-CDK-Panel)

The DIANA CDK Panel is an advanced selectivity profiling tool designed for drug discovery, enabling the precise measurement of enzyme dissociation constants (Kd) for target compounds against a comprehensive set of 24 Cyclin Dependent Kinases (CDKs). Utilizing our proprietary DIANA assay, this ultrasensitive panel offers a wide dynamic range, ensuring reliable Kd determination from a single well in a multi-well plate format.


Would you like to see the full DIANA CDK Panel leaflet? Download it here!

DIANA Technology Features

DIANA Technology: DIANA is patented solid-phase competitive binding assay that uniquely combines small molecule-based DIANA probes with the strengths of ELISA and qPCR.

Quantitative Results: Determination of quantitative potency data (Kd) from each measurement thanks to the proprietary DIANA technology.

Affordable Excellence: Our service has fast turnaround time and it is possible to fully customize the order. Finally, the pricing makes our top-tier solution accessible to everyone.

Internal Quality Control – Binding potency of known inhibitor is determined for each kinase

Service Information

Name

No. of kinases

Cpds

Price (EUR)

Turnaround time**

Result

DIANA CDK Panel

24

1

480

7 business days

Kd

Custom Selection

1

1

25*

7 business days

Kd

*Minimal Order Quantity for Custom Selection service is 500 EUR.

**Counts from the day compounds are delivered to our testing facility. For complex orders the turnaround time can be extended to 14 business days.

Comparative analysis of inhibition profile of Staurosporine

Axis decription:x: Kd (nM); log scale; y: Cpd concentration (nM); log scale

Profiling of selected kinase inhibitors by DIANA CDK panel (Kd)

Place your order

I agree to the Terms and Conditions

Related services

Customers who explored this service also showed interest in:

DIANA is a solid-phase competitive binding assay that uniquely combines small molecule-based DIANA probes with the strengths of ELISA and qPCR, delivering robust quantitative potency data with an exceptionally broad dynamic range. This allows researchers to obtain precise binding affinity constants (Kd) from the start of their projects at a cost comparable to conventional methods that only provide relative inhibition.

DIANA Kinase panel is an advanced kinase inhibitor selectivity profiling tool currently covering more than 170 kinases. Using proprietary DIANA technology it delivers quantitative affinity measurements (Kd) from single measurement.

DIANA TK panel is an advanced tyrosine kinase inhibitor selectivity profiling tool which comprise 68 different TKs. Using proprietary DIANA technology it delivers quantitative affinity measurements (Kd) from single measurement.

DIANA CK1 panel is an advanced CK1 (casein kinase 1) inhibitor selectivity profiling tool which comprise 7 different CK1s. Using proprietary DIANA technology it delivers quantitative affinity measurements (Kd) from single measurement.

DIANA CDK Panel | Collaboration

Interested in inhibitor profiling using DIANA CDK Panel? Send us a message!